Isotope and Patient Age Predict for PSA Spikes After Permanent Prostate Brachytherapy-Reference-Cited by-同舟云学术

Isotope and Patient Age Predict for PSA Spikes After Permanent Prostate Brachytherapy

Published:2007-08 Issue:5 Volume:68 Page:1431-1437
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Bostancic Chelsea,Merrick Gregory S.,Butler Wayne M.,Wallner Kent E.,Allen Zachariah,Galbreath Robert,Lief Jonathan,Gutman Sarah E.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference19 articles.

1. Evaluating cancer status;Wallner,1997

2. Prostate-specific antigen spikes after permanent prostate brachytherapy;Merrick;Int J Radiat Oncol Biol Phys,2002

3. Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: Descriptions and implications;Stock;Int J Radiat Oncol Biol Phys,2003

4. Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: The relationship to patient age;Critz;J Urol,2003

5. Transient elevation of serum prostate-specific antigen following I-125/Pd-103 brachytherapy for localized prostate cancer;Cavanagh;Semin Urol Oncol,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer;American Journal of Clinical Oncology;2022-05-06

2. Time to achieve a prostate-specific antigen nadir of ≤0.2 ng/mL and related factors after permanent prostate brachytherapy;Brachytherapy;2021-01

3. Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis;Cancers;2020-08-05

4. High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractions;Radiotherapy and Oncology;2018-05

5. Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer;Journal of Contemporary Brachytherapy;2018